Investments on Propel(x) are high risk, illiquid and bear the risk of partial or complete loss of invested capital. Please review risk factors for investments on Propel(x) here. This newsletter is for informational purposes only. It is not a solicitation to buy or sell a security.
GraphWear closes $20.5M Series B round led by Mayfield
GraphWear is pursuing a needle-free, glucose monitoring device which uses nanotechnology to detect biomolecules from the surface of the skin. This allows a person to self track key body metrics such as glucose levels, continuously without breaking the skin.
Zenflow's pivotal trial launched to pave the way for FDA clearance
The first patient in the pivotal BREEZE trial has been treated with the novel Spring System, a minimally invasive device developed by Zenflow and used to relieve lower urinary tract symptoms (LUTS) related to benign prostatic hyperplasia (BPH).
ICYMI: Frequently Used Terms in Investing and Startups
Are you new to the world of online investing or investing in startups? Do you get confused with the legal or technical jargon when it comes to alternative investments?
We identified some of the frequently used terms in our business which may be a helpful guide for you. Check it out and if you find it informative, please share with your network.
ICYMI: Deal Sourcing and Climate Tech w/ Jason Holt - Baruch Future Ventures
In this podcast episode, we chatted with Jason Holt from Baruch Future Ventures on how to build a quality efficient deal sourcing practice. Jason shared his perspective on how to distinguish good markets from bad markets, and
what to look for in company founders as an investor.
Propel(x) is a premier digital platform facilitating private venture capital for deep technology startups. Our mission is to
enable investment in technologies that matter
and thus build the next generation of great companies.